Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.
about
Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial.Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetes.
P2860
Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.
@en
Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.
@nl
type
label
Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.
@en
Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.
@nl
prefLabel
Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.
@en
Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.
@nl
P2093
P50
P356
P1433
P1476
Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.
@en
P2093
Anja Corner
Daniël H van Raalte
Michaela Diamant
P356
10.2337/DC15-2489
P407
P577
2015-12-30T00:00:00Z